Arterial hemorrhage is a major complication during brain surgeries, especially in elderly patients with fragile vasculature. Rapid and localized hemostasis is critical to prevent severe neurological damage. Tranexamic acid (TXA) is an antifibrinolytic agent effective in stabilizing blood clots, but systemic administration poses risks like seizures and thrombosis.